influenza
c
infc
viru
haemagglutinin
esteras
fusion
bovin
coronaviru
bcov
haemagglutinin
esteras
surfac
glycoprotein
exhibit
lectin
bind
capabl
receptordestroy
esteras
activ
recognis
acid
contain
glycan
report
nuclear
magnet
reson
molecular
model
studi
esteras
show
strictli
prefer
infc
bcov
esteras
interestingli
discov
infc
esteras
function
releas
acet
independ
chemic
natur
aglycon
moieti
wherea
subtl
differ
substrat
recognit
found
bcov
esteras
analysi
apo
complex
xray
crystal
structur
infc
esteras
reveal
bind
nacetylneuramin
acid
dynam
process
involv
conform
rearrang
esteras
activ
site
studi
provid
valuabl
insight
toward
design
drug
combat
infc
viru
coronaviru
infect
caus
outbreak
upper
respiratori
infect
sever
diarrhea
calv
respect
julian
mayr
thoma
haselhorst
made
equal
contribut
influenza
c
infc
viru
caus
outbreak
upper
respiratori
infect
worldwid
risk
complic
lowerrespiratorytract
ill
high
children
younger
year
age
contrast
influenza
b
virus
bind
nacetylneuramin
acid
infc
virus
strictli
employ
nacetylneuramin
acid
acid
receptor
fig
infc
haemagglutinin
esteras
fusion
hef
protein
serv
receptorbind
protein
display
receptordestroy
esteras
activ
promot
fusion
viral
endosom
membran
occur
ubiquit
also
nonsuit
host
cell
virion
solubl
insolubl
molecul
extracellular
environ
esteras
activ
provid
escap
ticket
virion
progeni
prevent
irrevers
nonproduct
bind
receptor
besid
infc
virus
infecti
salmon
anaemia
viru
torovirus
group
coronavirus
express
evolutionarili
relat
oacetylesteras
bovin
coronaviru
bcov
close
relat
human
respiratori
coronavirus
hku
caus
sever
diarrhoea
calv
winter
dysenteri
adult
cattl
result
loss
product
livestock
industri
viral
sialateoacetylesteras
repres
famili
serin
ser
hydrolas
coval
bind
serin
hydrolas
inhibitor
diisopropylfluorophosph
dfp
label
hdfp
activ
site
serin
residu
infc
viru
esteras
identifi
precursor
protein
proteolyt
remov
signal
peptid
correspond
matur
hef
protein
activ
site
serin
esteras
compos
charg
relay
system
also
term
catalyt
triad
matur
infc
hef
protein
triad
form
histidin
aspart
asp
gain
better
understand
mechan
mode
action
oacetylesteras
nuclear
magnet
reson
nmr
studi
combin
molecular
model
studi
receptordestroy
esteras
infc
viru
bcov
scheme
undertaken
specif
util
onedimension
h
nmr
spectroscopi
follow
enzymecatalyz
reaction
infc
bcov
esteras
use
number
nacetylneuramin
acid
deriv
nmrbase
enzym
assay
allow
simultan
monitor
consumpt
substrat
subsequ
buildup
product
nmr
molecular
model
experi
show
strictli
prefer
infc
bcov
esteras
interestingli
infc
esteras
function
releas
acet
complet
independ
chemic
natur
aglycon
moieti
infc
viru
hef
use
studi
compris
chimer
recombin
solubl
influenza
viru
haemagglutinin
esteras
protein
fuse
frame
enhanc
green
fluoresc
protein
protein
express
insect
cell
serumfre
media
recombin
baculovirus
purifi
cell
cultur
supernat
ultracentrifug
follow
applic
qsepharos
ff
column
esteras
dialyz
mm
naphosph
ph
freezedri
transport
lyophil
enzym
resolv
deuter
phosphat
buffer
use
nmr
analysi
esteras
activ
infc
viru
hef
coronaviru
determin
pnitrophenyl
acet
pnpa
describ
previous
one
milliunit
viral
esteras
activ
defin
amount
enzymat
activ
result
hydrolysi
nmol
pnpa
per
minut
ectodomain
residu
bcov
strain
mebu
express
fc
fusion
protein
human
embryon
kidney
cell
describ
previous
purifi
tissu
cultur
supernat
protein
aaffin
chromatographi
prepar
nacetylneuraminid
figur
show
nacetylneuraminid
use
studi
isol
bovin
submaxillari
mucin
acid
hydrolysi
purifi
previous
describ
follow
second
purif
dowex
mesh
anion
exchang
column
known
methyl
nacetylneuraminid
thiolink
nacetylneuraminosylglucosid
readili
synthes
correspond
nacetylneuraminid
isol
yield
respect
accord
publish
protocol
nmr
experi
nmrbase
infc
viru
bcov
esteras
assay
analys
bruker
k
deuter
mm
phosphat
buffer
mm
nacl
ph
h
nmr
spectra
acquir
scan
relax
delay
spectral
width
hz
solvent
suppress
residu
hdo
peak
achiev
continu
low
power
presatur
puls
relax
delay
data
acquisit
process
perform
xwinnmr
softwar
substrat
dissolv
nmr
buffer
mm
solut
total
volum
absenc
protein
prepar
h
nmr
spectrum
acquir
addit
mu
mu
bcov
h
nmr
spectra
record
min
interv
min
fig
ident
protocol
use
follow
reaction
bcov
esteras
fig
prior
nmrbase
enzym
assay
chemic
shift
assign
use
substrat
achiev
correl
spectroscopi
total
correl
spectroscopi
nuclear
overhaus
enhanc
spectroscopi
heteronuclear
singl
quantum
correl
nmr
experi
molecular
model
forc
torsion
grid
search
molecular
model
investig
perform
crystal
structur
protein
data
bank
acc
crystal
structur
pro
visual
insight
ii
accelri
insightii
accelri
inc
san
diego
ca
usa
softwar
forc
torsion
grid
search
use
carri
extract
structur
crystal
structur
use
start
point
build
use
insightii
three
torsion
angl
involv
linkag
forcibl
rotat
use
discov
discov
accelri
inc
san
diego
ca
usa
increment
intramolecular
energi
evalu
step
use
consist
valenc
forc
field
conform
within
kcalmol
lowest
energi
structur
extract
view
insightii
use
biosym
command
languag
macro
superimpos
ring
atom
sialic
acid
conform
onto
ring
atom
sialic
acid
crystal
structur
result
view
fig
conform
flexibl
display
rel
solvent
access
surfac
hef
activ
site
result
discuss
figur
show
h
nmr
spectrum
incub
infc
hef
h
dramat
reduct
signal
fig
intens
ppm
simultan
increas
intens
free
acet
signal
fig
ppm
could
detect
chang
intens
h
nmr
signal
methyl
proton
nacetamido
moieti
ppm
could
observ
deoacetyl
effect
chemic
shift
nacetamido
group
fig
studi
activ
infc
hef
toward
differ
substrat
determin
effect
aglycon
group
compar
timebas
acet
releas
fig
infc
hef
deoacetyl
three
substrat
fig
structur
nacetylneuraminid
ineffici
interestingli
cleav
similar
rate
conclud
substrat
rate
acet
releas
independ
chemic
composit
aglycon
moieti
methyl
sulfur
link
glucos
unit
respect
provid
evid
acet
releas
independ
chemic
composit
aglycon
unit
reexamin
xray
crystal
structur
infc
viru
hef
complex
glycosid
acid
sialic
acid
portion
disaccharid
superimpos
monosaccharid
sixtyfour
differ
conform
linkag
gener
access
ensembl
conform
four
figur
illustr
lowenergi
conform
superimpos
within
activ
site
infc
hef
immedi
obviou
select
conform
glucos
unit
appear
littl
interact
protein
surfac
observ
fig
superimposit
sialic
acid
portion
set
conform
methyl
within
activ
site
infc
hef
glucos
moieti
interact
protein
surfac
like
effect
acet
cleavag
releas
evid
aglycon
moieti
interact
protein
importantli
acet
cleavag
site
support
assumpt
rate
acet
releas
infc
hef
independ
chemic
composit
aglycon
moieti
reason
reduc
enzymat
activ
hef
toward
might
relat
solut
anomer
ratio
substrat
lock
wherea
anomer
ratio
determin
h
nmr
spectroscopi
data
shown
investig
directli
measur
acet
releas
strictli
substrat
nmrbase
enzym
assay
reveal
h
incub
infc
hef
signal
ppm
intens
compar
h
nmr
spectrum
absenc
enzym
observ
conclud
interact
hef
esteras
optim
manner
determin
whether
specif
infc
enzym
analyz
prototyp
esteras
group
coronavirus
bcov
comparison
rel
rate
acet
releas
catalyz
infc
viru
bcov
esteras
shown
fig
immedi
obviou
rate
acet
releas
bcov
higher
compar
enzym
slow
rate
acet
releas
detect
result
support
notion
bcov
esteras
similar
mode
action
compar
infc
viru
esteras
engag
effici
substrat
understand
observ
nmrbase
assay
result
molecular
atom
level
reexamin
xray
crystal
structur
infc
viru
hef
complex
glycosid
acid
shown
fig
catalyt
triad
infc
viru
hef
compos
carbonyl
oxygen
atom
orient
toward
oxyanion
hole
form
sidechain
nh
group
catalyt
residu
posit
nucleophil
attack
carbonyl
carbon
carboxyl
group
nacetylneuramin
acid
moieti
form
two
hydrogen
bond
arginin
arg
thu
provid
enhanc
substrat
bind
overal
evid
carboxyl
group
involv
major
contact
protein
investig
superimpos
relat
figur
show
orient
carboxyl
moieti
assum
overal
ident
bind
mode
molecular
model
studi
appar
esteras
could
inde
perfectli
accommod
glycosid
import
bidend
interact
carboxyl
would
disrupt
propos
loss
import
interact
provid
rationalis
suitabl
substrat
infc
viru
coronaviru
esteras
result
lead
us
suggest
two
absolut
essenti
pharmacophor
group
correct
spatial
arrang
requir
strong
ligand
interact
carboxyl
group
postul
moieti
fundament
requir
design
new
class
potent
esteras
inhibitor
base
carboxylatecontain
compound
structur
examin
apo
complex
infc
viru
receptordestroy
esteras
domain
reveal
previous
unobserv
remark
differ
provid
valuabl
insight
structurebas
drug
design
fig
strike
conform
rearrang
import
catalyt
amino
acid
attempt
dock
data
shown
bind
site
apo
blue
infc
viru
esteras
structur
fail
result
steric
hindranc
bind
domain
creat
carbonyl
oxygen
seen
carbonyl
oxygen
point
oxyanion
hole
apo
structur
fig
carbon
brown
prevent
bind
substrat
upon
complex
carbonyl
group
move
facilit
intern
hydrogen
bond
nitrogen
fig
atom
colour
conform
rearrang
open
bind
site
allow
bind
oacetyl
moieti
therefor
essenti
amino
acid
apo
structur
carbon
shown
brown
infc
viru
hef
complex
atom
colour
display
carboxyl
group
coo
also
shown
cyan
conform
rearrang
upon
substrat
bind
clearli
observ
respons
catalyt
activ
importantli
bind
orient
substrat
first
place
summari
shown
moieti
essenti
pharmacophor
group
infc
viru
hef
protein
rate
acet
releas
independ
type
aglycon
show
ident
rate
omethyl
slink
glucos
moieti
examin
structur
apo
viru
hef
suggest
catalyt
amino
acid
undergo
conform
chang
bind
nacetylneuraminid
combin
nmr
molecular
model
studi
provid
new
insight
import
enzym
pave
way
design
develop
novel
antivir
therapeut
